Minitran and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Minitran (nitroglycerin), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Omeprazole, and have High blood pressure.

The study is created by eHealthMe based on reports of 943 people who have side effects when taking Minitran from the FDA, and is updated regularly.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

On Jul, 10, 2026

943 people reported to have side effects when taking Minitran.
Among them, 15 people (1.59%) died.

Among these 15 people:

How long have people been on Minitran when they died? *

What is the gender of people who died when taking Minitran? *

female: 64.29 %
male: 35.71 %

What is the age of people who died when taking Minitran? *

What are other drugs people take besides Minitran? *

What are other side effects people have before they died? *

Pneumonia: 3 people, 20.00%
Hyperhidrosis (abnormally increased sweating): 2 people, 13.33%
Fall: 2 people, 13.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
Pain: 2 people, 13.33%
Chest Pain: 2 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%
Blood Creatinine Increased: 2 people, 13.33%
Anaemia (lack of blood): 2 people, 13.33%

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 20.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Parkinson's Disease: 2 people, 13.33%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
Diabetes: 2 people, 13.33%
Urinary Tract Infection: 1 person, 6.67%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%
Cardiac Disorder: 1 person, 6.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.67%
Depression: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Minitran:

Minitran (950 reports)

Expand to all the drugs that have ingredients of nitroglycerin:

Death and drugs with ingredients of nitroglycerin (2,808 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,135 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Minitran) and Minitran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.